Loading…

Landscape of coordinated immune responses to H1N1 challenge in humans

Influenza is a significant cause of morbidity and mortality worldwide. Here we show changes in the abundance and activation states of more than 50 immune cell subsets in 35 individuals over 11 time points during human A/California/2009 (H1N1) virus challenge monitored using mass cytometry along with...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of clinical investigation 2020-11, Vol.130 (11), p.5800-5816
Main Authors: Rahil, Zainab, Leylek, Rebecca, Schürch, Christian M, Chen, Han, Bjornson-Hooper, Zach, Christensen, Shannon R, Gherardini, Pier Federico, Bhate, Salil S, Spitzer, Matthew H, Fragiadakis, Gabriela K, Mukherjee, Nilanjan, Kim, Nelson, Jiang, Sizun, Yo, Jennifer, Gaudilliere, Brice, Affrime, Melton, Bock, Bonnie, Hensley, Scott E, Idoyaga, Juliana, Aghaeepour, Nima, Kim, Kenneth, Nolan, Garry P, McIlwain, David R
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Influenza is a significant cause of morbidity and mortality worldwide. Here we show changes in the abundance and activation states of more than 50 immune cell subsets in 35 individuals over 11 time points during human A/California/2009 (H1N1) virus challenge monitored using mass cytometry along with other clinical assessments. Peak change in monocyte, B cell, and T cell subset frequencies coincided with peak virus shedding, followed by marked activation of T and NK cells. Results led to the identification of CD38 as a critical regulator of plasmacytoid dendritic cell function in response to influenza virus. Machine learning using study-derived clinical parameters and single-cell data effectively classified and predicted susceptibility to infection. The coordinated immune cell dynamics defined in this study provide a framework for identifying novel correlates of protection in the evaluation of future influenza therapeutics.
ISSN:0021-9738
1558-8238
DOI:10.1172/JCI137265